Michael Brasfield
Internal Medicine · Jasper, ALNPI 1194734665
Payments from drug & device makers
Across 157 payments — averaging $14.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$565
- AbbVie$478
- Novo Nordisk$301
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$150
- Pfizer$121
- Amgen$114
- plus $525 from 17 others
What the payments were for
- Food & beverage$2,22899%
- Education$251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 39 | $565 |
| AbbVie(2 entities) | 43 | $478 |
| Novo Nordisk | 19 | $301 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $150 |
| Pfizer | 8 | $121 |
| Amgen | 7 | $114 |
| Novartis | 6 | $93 |
| AstraZeneca | 5 | $87 |
| Astellas Pharma US Inc | 3 | $43 |
| Lilly USA, LLC | 2 | $40 |
| GSK | 2 | $34 |
| Boehringer Ingelheim | 2 | $28 |
| Intra-sana Laboratories | 1 | $28 |
| Kowa Pharmaceuticals America, Inc. | 2 | $25 |
| Merck | 1 | $21 |
| Abbott | 1 | $20 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $17 |
| Evoke Pharma, Inc. | 1 | $16 |
| Boston Scientific | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Tactile Systems Technology Inc | 1 | $14 |
How this compares
$2,253 in reported general payments places this provider in the 70th percentile of 1,533 internal medicine providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 13 | $5,047 |
| DuleraMometasone/Formoterol | 12 | $4,392 |
| OsphenaOspemifene | 26 | $3,223 |
| Divalproex Sodium | 13 | $1,663 |
| Pantoprazole Sodium | 20 | $652 |
| Buspirone Hcl | 13 | $556 |
| Trazodone Hcl | 20 | $432 |
| Furosemide | 34 | $275 |
| Tamsulosin Hcl | 13 | $247 |
| Potassium Chloride | 11 | $220 |
| Levothyroxine Sodium | 13 | $191 |
| Amlodipine Besylate | 11 | $176 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $478 | $5,04713 claims |
| MerckDulera | $21 | $4,39212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,533 internal medicine providers in Alabama.
Other internal medicine in Jasper
- Sonja PettusJasper$117K
- Harry StuddardMobile$12.9M
- Almena FreeAnniston$12.7M
- Hayes WilliamsVestavia$10.4M
- David DeatkineBirmingham$8M
- James SullivanBirmingham$6M
- Ramy TomaBirmingham$5.1M
- Barry McLeanHomewood$4M
- William KirbyBirmingham$2.3M
- Saadat AnsariHuntsville$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.